Form 4: ADC Therapeutics Director Sells Shares to Cover Tax Obligations

Director Thomas Pfisterer sold 1,437 common shares of ADC Therapeutics SA to cover tax withholding obligations related to the vesting and settlement of restricted share units.

Summary

• On June 17, 2024, Thomas Pfisterer, a director of ADC Therapeutics SA, sold 1,437 common shares at a price of $2.89 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of restricted share units.
• Following the transaction, Pfisterer directly owns 213,900 common shares.
• Pfisterer also indirectly owns 451,856 common shares through HPWH TH AG.
• He disclaims beneficial ownership of the shares held by HPWH TH AG, except for the portion represented by his indirect interest through HPWH MH AG.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares for tax obligations) by a company director, which is neither particularly positive nor negative.

Industry Context

This transaction is a routine disclosure related to insider trading regulations and doesn't necessarily indicate a change in the director's confidence in the company.

Stakeholder Impact

• The sale of shares by a director could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates